{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:52:57Z","timestamp":1761738777442,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jasc.2024.11.003","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T18:30:08Z","timestamp":1732991408000},"page":"86-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Benchmarking high-risk human papillomavirus testing against cytology and biopsy results in the detection of cervical dysplasia to inform clinical screening guidelines"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9054-1606","authenticated-orcid":false,"given":"Divya","family":"Salibindla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9858-8292","authenticated-orcid":false,"given":"Rachel","family":"Jug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2024.11.003_bib1","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement","volume":"156","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jasc.2024.11.003_bib2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2024.11.003_bib3","first-page":"147","article-title":"American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2024.11.003_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: The HPV FOCAL randomized clinical trial","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2024.11.003_bib5","first-page":"321","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2024.11.003_bib6","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1136\/ijgc-2020-001457","article-title":"HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: A prospective study","volume":"30","author":"Andersen","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jasc.2024.11.003_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279728","article-title":"High sensitivity and specificity rates of cobas\u00ae HPV test as a primary screening test for cervical intraepithelial lesions in a real-world setting","volume":"18","author":"Fleider","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2024.11.003_bib8","first-page":"156","article-title":"Age-specific screening strategies for cervical cancer: a review","volume":"224","author":"Cohen","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jasc.2024.11.003_bib9","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jasc.2024.11.003_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6627531","article-title":"Progression of CIN1\/LSIL HPV persistent of the cervix: actual progression or CIN3 coexistence","volume":"2021","author":"Bruno","year":"2021","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.jasc.2024.11.003_bib12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cam4.1961","article-title":"Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-Potential for prevention","volume":"8","author":"Dovey de la Cour","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.jasc.2024.11.003_bib13","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jasc.2023.07.034","article-title":"A study of cervical cytology on pap smears with positive high-risk human papillomavirus (hrHPV) tests with Non-HPV 16\/18\/45 subtypes","volume":"12","author":"Addo","year":"2023","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.11.003_bib14","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.3802\/jgo.2016.27.e21","article-title":"Clinical significance of human papillomavirus genotyping","volume":"27","author":"Choi","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.jasc.2024.11.003_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jasc.2024.09.003","article-title":"Triage options for positive high-risk HPV results from HPV-based cervical cancer screening: a review of the potential alternatives to Papanicolaou test cytology","volume":"14","author":"Thrall","year":"2025","journal-title":"J\u00a0Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2024.11.003_bib16","first-page":"104","article-title":"Role of p16\/INK4a and Ki-67 as specific biomarkers for cervical intraepithelial neoplasia: An institutional study","volume":"9","author":"Hebbar","year":"2017","journal-title":"J\u00a0Lab Physicians"},{"key":"10.1016\/j.jasc.2024.11.003_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jnci\/djaa066","article-title":"Accuracy and efficiency of deep-learning\u2013based automation of dual stain cytology in cervical cancer screening","volume":"113","author":"Wentzensen","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jasc.2024.11.003_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294524002412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294524002412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:22:15Z","timestamp":1761715335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294524002412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213294524002412"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2024.11.003","relation":{},"ISSN":["2213-2945"],"issn-type":[{"type":"print","value":"2213-2945"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benchmarking high-risk human papillomavirus testing against cytology and biopsy results in the detection of cervical dysplasia to inform clinical screening guidelines","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2024.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society of Cytopathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}